Tesollo Plans IPO While Expanding Humanoid Hands Portfolio

Tesollo is going public as it scales high-DOF humanoid hands. The Incheon-based company has officially begun preparations for an initial public offering in the coming year, while it continues to push a global expansion agenda for its robotic end effectors and autonomy tech. Testing shows the move comes alongside progress on its product line, which ranges from DG-2F parallel grippers to more dexterous five-fingered hands and a notable three-fingered DG-3 demonstrator that Tesollo showcased at AW 2026.

Documentation indicates the IPO plan is paired with a push to deepen mass production capabilities. The company reports that completing its Series B round is intended to fuel its scale and entry into overseas markets. Leadership frames the IPO as a step to build a corporate foundation that global customers can trust, while accelerating expansion beyond Korea into the United States, China, and Japan. In a signal of ambition, Tesollo says overseas sales recently surpassed domestic sales, marking a shift toward a truly global footprint after starting operations in 2019. The same source notes that the company has exported products to 19 countries, underscoring a breadth of early adoption across diverse application domains.

The investor syndicate emerging from the Series B round reads like a cross-section of Korea's industrial tech biology. Existing shareholders, including POSCO Technology Investment, KB Investment, and Enlight Ventures, participated as follow-on investors, while strategic backers from manufacturing and automotive sectors, such as Daesung Hi-Tech and HL Mando, joined the round. The company reports that the mix of financial and strategic support is evidence of recognition of Tesollo's core technology and growth potential, a point that matters as it lines up customers in multiple continents. Tesollo's leadership frames the IPO as a means to accelerate its global expansion, while ensuring that its supply chain can support the ramp of production in a market where co-development with robot vendors is common.

From a product and market perspective, Tesollo's focus remains on end effectors that can slot into a broad range of humanoid platforms. The DG-3 three-finger gripper demonstrated in March at AW 2026 points to a strategy of modular, scalable hands that can be adapted to different robot bodies, rather than a single bespoke system. The company's lineup, including DG-2F parallel grippers and the five-fingered family hinted at by the release, shows an emphasis on increasing degrees of freedom and controllability in a way that can feed directly into robot autonomy and manipulation tasks. If the hands can be produced at scale with reliable performance, Tesollo's customers, including robot manufacturers, integrators, and end users, will want predictable cycles from prototype to high-volume production.

Two practitioner takeaways emerge from the current moment. First, scale is a governance and cost challenge as much as a capability one. IPO funding is positioned to shore up manufacturing throughput for high-DOF hands, but the underlying constraint remains the cost of materials, control electronics, and precision assembly at volume. Second, the alignment between product maturity and channel strategy matters. Tesollo's overseas expansion rests not just on sales but on a robust, serviceable ecosystem, such as local supply chains, spare parts logistics, and support in multiple languages, areas where the early export push will face the most practical tests as orders grow.

Longer term, the story hinges on whether Tesollo can convert its demonstrated prototypes into repeatable, reliable units across factory floors. If the DG-3 and broader end-effectors prove durable under real-world loads and long cycles, the IPO could fund the scale needed to compete in a market where robots increasingly rely on dexterous hands to unlock true autonomy.